US Stock MarketDetailed Quotes

SXTP 60 Degrees Pharmaceuticals

Watchlist
  • 1.410
  • -0.240-14.55%
Close Dec 13 16:00 ET
  • 1.400
  • -0.010-0.71%
Post 19:50 ET
3.24MMarket Cap-0.44P/E (TTM)

60 Degrees Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
164.31%135.29K
109.92%124.97K
578.21%116.46K
13.60%253.57K
438.09%125.68K
-69.56%51.19K
31.79%59.53K
-63.48%17.17K
-80.76%223.21K
-226.17%-37.17K
Operating revenue
164.31%135.29K
109.92%124.97K
578.21%116.46K
13.60%253.57K
438.09%125.68K
-69.56%51.19K
31.79%59.53K
-63.48%17.17K
-80.76%223.21K
-226.17%-37.17K
Cost of revenue
56.87%111.69K
-51.32%89.56K
-10.51%65.44K
9.76%474.55K
-10.18%146.26K
-22.85%71.2K
111.18%183.98K
-18.88%73.12K
-49.18%432.37K
127.36%162.84K
Gross profit
217.98%23.61K
128.45%35.41K
191.20%51.03K
-5.65%-220.98K
89.71%-20.58K
-126.36%-20.01K
-196.67%-124.45K
-29.78%-55.95K
-167.56%-209.16K
-374.46%-200.01K
Operating expense
42.65%2.14M
536.60%4.22M
54.54%1.38M
220.10%4.93M
286.55%1.87M
416.03%1.5M
2.88%663.55K
641.87%894.72K
7.50%1.54M
10.22%484.69K
Selling and administrative expenses
-7.50%1.22M
144.07%1.13M
38.72%1.08M
225.36%4.24M
446.06%1.69M
217.58%1.31M
14.03%462.8K
343.65%775.01K
16.89%1.3M
17.63%309.57K
-General and administrative expense
-7.50%1.22M
144.07%1.13M
38.72%1.08M
225.36%4.24M
446.06%1.69M
217.58%1.31M
14.03%462.8K
343.65%775.01K
16.89%1.3M
17.63%309.57K
Research and development costs
256.49%940.06K
1,418.27%3.1M
171.93%337.18K
31.62%691.77K
-50.75%100.2K
853.55%263.7K
-11.89%203.87K
96.64%123.99K
-90.46%525.56K
-53.09%203.46K
Other operating expenses
83.04%-12.82K
76.64%-728
-590.38%-29.63K
----
----
49.71%-75.57K
-140.26%-3.12K
96.34%-4.29K
94.45%-288K
88.98%-28.33K
Operating profit
-39.23%-2.12M
-431.57%-4.19M
-40.08%-1.33M
-194.47%-5.15M
-176.64%-1.89M
-607.41%-1.52M
-14.71%-788K
-480.69%-950.66K
-55.72%-1.75M
-42.09%-684.7K
Net non-operating interest income expense
96.34%-1.47K
99.67%-3.62K
99.88%-1.4K
42.68%-2.29M
99.51%-5.45K
96.70%-40.11K
-21.44%-1.1M
-49.75%-1.14M
-25.74%-3.99M
-20.04%-1.11M
Non-operating interest expense
-96.34%1.47K
-99.67%3.62K
-99.88%1.4K
-42.68%2.29M
-99.51%5.45K
-96.70%40.11K
21.44%1.1M
49.75%1.14M
25.74%3.99M
20.04%1.11M
Other net income (expense)
-100.70%-40.09K
101.28%18.58K
448.47%1.76M
929.22%3.63M
-221.68%-146.55K
29,782.10%5.74M
-161.22%-1.46M
-2,797.94%-505.38K
-1,266.15%-437.48K
215.48%120.44K
Gain on sale of security
-161.32%-56.71K
99.72%-1.1K
34,008.20%1.74M
15.13%-437K
-1,105.78%-132.6K
511.16%92.49K
22.52%-391.76K
---5.13K
---514.93K
--13.18K
Special income (charges)
--0
--0
--0
-1,120.43%-1.23M
--0
---391.59K
--0
---839.89K
--120.68K
--120.68K
-Less:Other special charges
----
----
----
1,120.43%1.23M
--0
--391.59K
----
--839.89K
---120.68K
----
Other non- operating income (expenses)
-99.72%16.62K
101.85%19.68K
-94.03%20.26K
12,348.84%5.3M
-3.87%-13.95K
190,145.15%6.03M
-1,957.70%-1.06M
1,713.17%339.64K
-215.26%-43.24K
-135.17%-13.43K
Income before tax
-151.76%-2.16M
-24.83%-4.17M
116.48%428.05K
38.26%-3.81M
-22.53%-2.05M
387.75%4.17M
-55.53%-3.34M
-186.32%-2.6M
-45.03%-6.18M
-22.36%-1.67M
Income tax
296.83%250
595.24%438
0.00%63
-50.00%250
124.40%61
-74.80%63
-74.80%63
-74.80%63
-50.00%500
-200.00%-250
Net income
-151.77%-2.16M
-24.84%-4.17M
116.48%427.99K
38.27%-3.81M
-22.55%-2.05M
387.70%4.17M
-55.51%-3.34M
-186.25%-2.6M
-45.01%-6.18M
-22.32%-1.67M
Net income continuous Operations
-151.77%-2.16M
-24.84%-4.17M
116.48%427.99K
38.27%-3.81M
-22.55%-2.05M
387.70%4.17M
-55.51%-3.34M
-186.25%-2.6M
-45.01%-6.18M
-22.32%-1.67M
Minority interest income
92.62%-713
79.09%-1.47K
-198.34%-2.49K
-1,322.00%-48.1K
-729.55%-33.93K
-204.41%-9.66K
-125.73%-7.04K
-47.74%2.53K
146.01%3.94K
235.19%5.39K
Net income attributable to the parent company
-151.63%-2.16M
-25.06%-4.17M
116.56%430.47K
39.08%-3.77M
-20.13%-2.01M
389.00%4.18M
-55.41%-3.34M
-185.01%-2.6M
-45.39%-6.18M
-23.07%-1.68M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-151.63%-2.16M
-25.06%-4.17M
116.56%430.47K
39.08%-3.77M
-20.13%-2.01M
389.00%4.18M
-55.41%-3.34M
-185.01%-2.6M
-45.39%-6.18M
-23.07%-1.68M
Basic earnings per share
-110.19%-0.93
42.80%-4.112
106.43%0.36
10.80%-11.88
-46.58%-5.29
392.75%9.13
-55.41%-7.1889
-185.01%-5.602
-45.39%-13.319
-23.07%-3.609
Diluted earnings per share
-110.19%-0.93
42.80%-4.112
106.43%0.36
10.80%-11.88
-46.58%-5.29
392.75%9.13
-55.41%-7.1889
-185.01%-5.602
-45.39%-13.319
-23.07%-3.609
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 164.31%135.29K109.92%124.97K578.21%116.46K13.60%253.57K438.09%125.68K-69.56%51.19K31.79%59.53K-63.48%17.17K-80.76%223.21K-226.17%-37.17K
Operating revenue 164.31%135.29K109.92%124.97K578.21%116.46K13.60%253.57K438.09%125.68K-69.56%51.19K31.79%59.53K-63.48%17.17K-80.76%223.21K-226.17%-37.17K
Cost of revenue 56.87%111.69K-51.32%89.56K-10.51%65.44K9.76%474.55K-10.18%146.26K-22.85%71.2K111.18%183.98K-18.88%73.12K-49.18%432.37K127.36%162.84K
Gross profit 217.98%23.61K128.45%35.41K191.20%51.03K-5.65%-220.98K89.71%-20.58K-126.36%-20.01K-196.67%-124.45K-29.78%-55.95K-167.56%-209.16K-374.46%-200.01K
Operating expense 42.65%2.14M536.60%4.22M54.54%1.38M220.10%4.93M286.55%1.87M416.03%1.5M2.88%663.55K641.87%894.72K7.50%1.54M10.22%484.69K
Selling and administrative expenses -7.50%1.22M144.07%1.13M38.72%1.08M225.36%4.24M446.06%1.69M217.58%1.31M14.03%462.8K343.65%775.01K16.89%1.3M17.63%309.57K
-General and administrative expense -7.50%1.22M144.07%1.13M38.72%1.08M225.36%4.24M446.06%1.69M217.58%1.31M14.03%462.8K343.65%775.01K16.89%1.3M17.63%309.57K
Research and development costs 256.49%940.06K1,418.27%3.1M171.93%337.18K31.62%691.77K-50.75%100.2K853.55%263.7K-11.89%203.87K96.64%123.99K-90.46%525.56K-53.09%203.46K
Other operating expenses 83.04%-12.82K76.64%-728-590.38%-29.63K--------49.71%-75.57K-140.26%-3.12K96.34%-4.29K94.45%-288K88.98%-28.33K
Operating profit -39.23%-2.12M-431.57%-4.19M-40.08%-1.33M-194.47%-5.15M-176.64%-1.89M-607.41%-1.52M-14.71%-788K-480.69%-950.66K-55.72%-1.75M-42.09%-684.7K
Net non-operating interest income expense 96.34%-1.47K99.67%-3.62K99.88%-1.4K42.68%-2.29M99.51%-5.45K96.70%-40.11K-21.44%-1.1M-49.75%-1.14M-25.74%-3.99M-20.04%-1.11M
Non-operating interest expense -96.34%1.47K-99.67%3.62K-99.88%1.4K-42.68%2.29M-99.51%5.45K-96.70%40.11K21.44%1.1M49.75%1.14M25.74%3.99M20.04%1.11M
Other net income (expense) -100.70%-40.09K101.28%18.58K448.47%1.76M929.22%3.63M-221.68%-146.55K29,782.10%5.74M-161.22%-1.46M-2,797.94%-505.38K-1,266.15%-437.48K215.48%120.44K
Gain on sale of security -161.32%-56.71K99.72%-1.1K34,008.20%1.74M15.13%-437K-1,105.78%-132.6K511.16%92.49K22.52%-391.76K---5.13K---514.93K--13.18K
Special income (charges) --0--0--0-1,120.43%-1.23M--0---391.59K--0---839.89K--120.68K--120.68K
-Less:Other special charges ------------1,120.43%1.23M--0--391.59K------839.89K---120.68K----
Other non- operating income (expenses) -99.72%16.62K101.85%19.68K-94.03%20.26K12,348.84%5.3M-3.87%-13.95K190,145.15%6.03M-1,957.70%-1.06M1,713.17%339.64K-215.26%-43.24K-135.17%-13.43K
Income before tax -151.76%-2.16M-24.83%-4.17M116.48%428.05K38.26%-3.81M-22.53%-2.05M387.75%4.17M-55.53%-3.34M-186.32%-2.6M-45.03%-6.18M-22.36%-1.67M
Income tax 296.83%250595.24%4380.00%63-50.00%250124.40%61-74.80%63-74.80%63-74.80%63-50.00%500-200.00%-250
Net income -151.77%-2.16M-24.84%-4.17M116.48%427.99K38.27%-3.81M-22.55%-2.05M387.70%4.17M-55.51%-3.34M-186.25%-2.6M-45.01%-6.18M-22.32%-1.67M
Net income continuous Operations -151.77%-2.16M-24.84%-4.17M116.48%427.99K38.27%-3.81M-22.55%-2.05M387.70%4.17M-55.51%-3.34M-186.25%-2.6M-45.01%-6.18M-22.32%-1.67M
Minority interest income 92.62%-71379.09%-1.47K-198.34%-2.49K-1,322.00%-48.1K-729.55%-33.93K-204.41%-9.66K-125.73%-7.04K-47.74%2.53K146.01%3.94K235.19%5.39K
Net income attributable to the parent company -151.63%-2.16M-25.06%-4.17M116.56%430.47K39.08%-3.77M-20.13%-2.01M389.00%4.18M-55.41%-3.34M-185.01%-2.6M-45.39%-6.18M-23.07%-1.68M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -151.63%-2.16M-25.06%-4.17M116.56%430.47K39.08%-3.77M-20.13%-2.01M389.00%4.18M-55.41%-3.34M-185.01%-2.6M-45.39%-6.18M-23.07%-1.68M
Basic earnings per share -110.19%-0.9342.80%-4.112106.43%0.3610.80%-11.88-46.58%-5.29392.75%9.13-55.41%-7.1889-185.01%-5.602-45.39%-13.319-23.07%-3.609
Diluted earnings per share -110.19%-0.9342.80%-4.112106.43%0.3610.80%-11.88-46.58%-5.29392.75%9.13-55.41%-7.1889-185.01%-5.602-45.39%-13.319-23.07%-3.609
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Tesla
TSLA
+4.34%
MicroStrategy
MSTR
+4.20%
MARA Holdings
MARA
+0.66%
Apple
AAPL
+0.07%
Microsoft
MSFT
-0.51%

Unlock the Full List